Resources Contact Us Home
Modified factor VIII

Image Number 3 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Roll of continuous web of optical film laminate and production method therefor
Method and composition for improving skin barrier function
Image forming apparatus
Sensor coating
Auto-provisioning of network services over an Ethernet access link
Multi-touch recognition resistive touch screen for recognizing multi-touch coordinates through capacitor charging time
Advertisement in operating system
  Randomly Featured Patents
Method, system and apparatus for determining prognosis in atrial fibrillation
Coating fluid holding member and oil coating roller using the same
Pickup camper hold down
Indicator needle of automotive instrument and method of manufacturing the same
Toy vehicle with pivoting axle
Smart browsing providers
Polymer electrolyte materials based on block copolymers
Wide-band transistor amplifier
Power-operated seat device for vehicle
Electrophotography recording method and recording apparatus using the method